Werewolf Therapeutics, Inc.
NASDAQ:HOWLBiotechnology
Healthcare
$1.03 +6.12%
+$0.06 today
- Market cap
- $50.06M
- Beta
- 0.29
- P/E (TTM)
- -1.4
- EPS (TTM)
- -$0.71
52W Low $0.27High $1.83
Volume 1.85M
Average 5.09M
Balance Sheet
Inspect the capital base behind the business.
Assets
$69.40M
FY 2025 · Annual
-45.3% YoYLiabilities
$44.59M
FY 2025 · Annual
-16.7% YoYEquity
$24.80M
FY 2025 · Annual
-66.2% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 157.53M | 129.32M | 134.34M | 111M | 57.95M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 6.93M | 1.35M | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 100K | 3.96M | 2.68M | 2.07M | 635K |
| Total Current Assets | 161.07M | 140.2M | 138.37M | 113.07M | 58.59M |
| Property, Plant & Equipment (Net) | 16.33M | 17.45M | 14.85M | 12.32M | 9.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 1.21M | 21.02M | 1.22M | 901K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.86M | 1.38M | 594K | 320K | 5K |
| Total Non-current Assets | 18.18M | 20.05M | 36.46M | 13.86M | 10.81M |
| Total Assets | 179.25M | 160.25M | 174.83M | 126.93M | 69.4M |
| Account Payables | 2.04M | 1.22M | 1.34M | 3.04M | 754K |
| Short-term Debt | 0 | 0 | 6.67M | 0 | 1.75M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 6.53M | 907K | 0 | 0 |
| Other Current Liabilities | 163K | 11.02M | 3.63M | 3.62M | 33.64M |
| Total Current Liabilities | 11.87M | 23.99M | 19.38M | 15.18M | 36.15M |
| Long-term Debt | 0 | 0 | 32.66M | 26.1M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 1.32M | 433K | 2.83M | 759K |
| Total Non-current Liabilities | 14.59M | 13.92M | 44.08M | 38.36M | 8.44M |
| Total Liabilities | 26.46M | 37.91M | 63.46M | 53.54M | 44.59M |
| Common Stock | 2K | 3K | 4K | 5K | 5K |
| Retained Earnings | (252.9M) | (306.71M) | (344.07M) | (414.59M) | (475.41M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 152.79M | 122.34M | 111.37M | 73.39M | 24.81M |
| Total Debt | 15.66M | 14.68M | 51.92M | 37.09M | 9.44M |
| Net Debt | (141.87M) | (114.63M) | (82.42M) | (73.91M) | (48.52M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $22.0M |
| Other Current | $905.0K |
| Total Current Assets | $22.9M |
| PP&E (Net) | $1.3M |
| Total Non-current Assets | $1.3M |
| Total Assets | $24.2M |
Analysis
Selected assets total $24.2M for Latest. The largest visible component is Cash & Equivalents at $22.0M, about 91.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 16, 2026 | |
| 10-Q | Quarterly report | Nov 13, 2026 | |
| EFFECT | EFFECT filing | Nov 12, 2026 | |
| 424B3 | 424B3 filing | Nov 12, 2026 | |
| S-4/A | S-4/A filing | Nov 10, 2026 |
How much cash does HOWL have?
Werewolf Therapeutics, Inc. (HOWL) reported $57.95M in cash and equivalents in fiscal 2025.
How much debt does HOWL carry?
Werewolf Therapeutics, Inc. (HOWL) reported $9.44M of total debt, with net debt of -$48.52M.
Continue the stock analysis
Jump to another research area for this company.